Publication | Closed Access

Oral administration of a matrix metalloproteinase inhibitor, CGS 27023A, protects the cartilage proteoglycan matrix in a partial meniscectomy model of osteoarthritis in rabbits

Cgs 27023AMatrix Metalloproteinase InhibitorMusculoskeletal ResearchCartilage DegenerationPathologyOsteoarthritisCartilage Proteoglycan MatrixJoint ReplacementMatrix BiologyMedicineOrthopaedic SurgeryExtracellular MatrixConnective Tissue Disease